Johnson & Johnson (JNJ) Stock Price, Quote & News

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 732 524 0400

Website: www.jnj.com

Address:

One Johnson & Johnson Plaza, New Brunswick, United States

scientificway Aug. 15 at 3:05 AM

$JNJ ready to move up, XTNT, shooting start, how much one month later?

0 · Reply

clan Aug. 14 at 11:59 PM

$ELTP For Elite, this is just crazy-huge growth yr/yr! $TEVA $JNJ $AMGN are watching👀

1 · Reply

2btheman Aug. 14 at 9:44 PM

$JNJ finally in the green from when this used to be a 190 dollar stock

0 · Reply

beau_mcg Aug. 14 at 8:38 PM

Seeing a little after hours move, but I think that $JNJ ends the month on a good little bump. Thinking we hit $177.5 tomorrow after other moves in market.

0 · Reply

PittsburghTrader Aug. 14 at 8:28 PM

$JNJ $176, $177 tomorrow?

0 · Reply

PittsburghTrader Aug. 14 at 7:26 PM

$JNJ Giddiup...in for bullish swing, let’s get solid close & bounce into the weekend

0 · Reply

PittsburghTrader Aug. 14 at 5:44 PM

$JNJ Giddiup… close back > $175

0 · Reply

SqueezeGod Aug. 14 at 4:42 PM

$JNJ most uneventful breakout from multiyear 170 resistance. It’s been two weeks and it's barely up 2%. One has to think acceleration is coming.

0 · Reply

PittsburghTrader Aug. 14 at 3:28 PM

$JNJ retakes $175?

0 · Reply

NeverFadeTheOracle Aug. 14 at 3:19 PM

$JNJ Dereg for pharma production Bullish for JNJ

0 · Reply

Back To Basics: Why I Favor Amgen Over Johnson & Johnson

AMGN

Aug 11, 2025, 4:29 PM EDT - 3 days ago

10 stocks with recently increased dividends — and why they merit a closer look

ADM CMCSA GIS MDT OZK PNC PRU

Aug 7, 2025, 12:23 PM EDT - 7 days ago

August Dogs Of The Dow Unleashed 19 'Safer' Dividend Buys

AMGN AMZN BA CRM CVX DIS HD

Aug 4, 2025, 5:12 PM EDT - 10 days ago

Why Johnson & Johnson Stock Still Has Room To Run

Aug 2, 2025, 8:01 AM EDT - 12 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)

ADP AMH APH ARCC ASR AVGO BTI

Aug 1, 2025, 12:01 PM EDT - 13 days ago

Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

ABBV AMGN AZN BMY GILD GSK LLY

Aug 1, 2025, 9:11 AM EDT - 13 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

BAX MDT

Aug 1, 2025, 8:31 AM EDT - 13 days ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

Aug 1, 2025, 6:54 AM EDT - 13 days ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Jul 31, 2025, 3:35 PM EDT - 14 days ago

Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says

ABBV AMGN AZN BMY GILD GSK LLY

Jul 31, 2025, 3:00 PM EDT - 14 days ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days.

ABBV AMGN AZN BMY GILD GSK LLY

Jul 31, 2025, 2:28 PM EDT - 14 days ago

Trump pressures 17 pharma CEOs to cut US drug prices

ABBV AMGN AZN BMY GILD GSK LLY

Jul 31, 2025, 2:19 PM EDT - 14 days ago

Trump posts letters to 17 pharmaceutical companies about drug prices

ABBV GILD LLY PFE AMGN AZN BMY

Jul 31, 2025, 1:48 PM EDT - 14 days ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

ABBV AMGN AZN BMY GILD GSK LLY

Jul 30, 2025, 4:32 PM EDT - 15 days ago

Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Jul 29, 2025, 7:11 PM EDT - 16 days ago

Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case

Jul 29, 2025, 8:03 AM EDT - 16 days ago

Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions

Jul 29, 2025, 8:00 AM EDT - 16 days ago

Johnson & Johnson files with U.S. FDA to include new evidence in TREMFYA® (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active psoriatic arthritis

Jul 27, 2025, 12:14 PM EDT - 18 days ago

22 Dividend Kings At Discounted Valuations

ABM ADM AMZN AWR BDX BKH CWT

Jul 27, 2025, 11:45 AM EDT - 18 days ago

20 Kiplinger July Dividend Favorites: No Cigars

APD BDX DUK EPD GS HD KVUE

Jul 25, 2025, 1:49 PM EDT - 20 days ago

3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs

LLY NVS

Jul 25, 2025, 11:48 AM EDT - 20 days ago

US FDA says J&J's Ethicon issues correction related to surgical stapler

Jul 24, 2025, 4:30 PM EDT - 21 days ago

Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

Jul 23, 2025, 6:00 PM EDT - 22 days ago

How To Build A $100,000 Dividend Portfolio: Targeting A Yield Of 15%+ In 20 Years

AAPL BLK GOOG GOOGL HDV PEP RQI

Jul 22, 2025, 3:11 PM EDT - 23 days ago

Johnson & Johnson Stock Could Be Waking Up

Jul 22, 2025, 9:31 AM EDT - 23 days ago

Best Dividend Kings: July 2025

ABBV ABM ABT ADM ADP AWR BDX

Jul 21, 2025, 10:50 AM EDT - 24 days ago

Insider report: These stocks had the biggest sales by executives in the past week

AVAV COST DFH HEI MS PAYX

Jul 21, 2025, 8:00 AM EDT - 24 days ago

Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasis

Jul 17, 2025, 8:05 PM EDT - 4 weeks ago

Jim Cramer explains why Johnson & Johnson rallied after 'surprise' earnings results

Jul 17, 2025, 7:47 PM EDT - 4 weeks ago

JNJ gave us a manual on how to spot a stock that can soar after earnings, says Jim Cramer

Jul 17, 2025, 4:37 PM EDT - 4 weeks ago

Stock Of The Day: Breakout In Johnson & Johnson

Jul 17, 2025, 12:40 PM EDT - 4 weeks ago

Johnson & Johnson: The Worst Is Baked In

Jul 17, 2025, 9:32 AM EDT - 4 weeks ago

Johnson & Johnson Analysts Raise Their Forecasts After Upbeat Earnings

Jul 17, 2025, 8:00 AM EDT - 4 weeks ago

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer

Jul 17, 2025, 7:59 AM EDT - 4 weeks ago

Dow Futures flat amid latest Trump vs Powell fiasco: 5 things to know before Wall Street opens today

Jul 16, 2025, 5:40 PM EDT - 4 weeks ago

S&P 500 Gains and Losses Today: Johnson & Johnson Stock Jumps; Universal Health Services Shares Slide

UHS

Jul 16, 2025, 4:00 PM EDT - 4 weeks ago

JNJ Technicals & Takeaways After Earnings, Healthcare Reaching Key Levels

Jul 16, 2025, 3:36 PM EDT - 4 weeks ago

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

Jul 16, 2025, 2:10 PM EDT - 4 weeks ago

Johnson & Johnson Stock Jumps on Strong Earnings, Higher Outlook

Jul 16, 2025, 1:52 PM EDT - 4 weeks ago

Final Trades: Johnson & Johnson, ICE and the IBIT

IBIT ICE

Jul 16, 2025, 12:40 PM EDT - 4 weeks ago

Top Stock Movers Now: J&J, ASML, Tesla, and More

Jul 16, 2025, 11:30 AM EDT - 4 weeks ago

J&J CFO: We're pleased with the engagement with the Trump administration

Jul 16, 2025, 10:51 AM EDT - 4 weeks ago

Cramer's Mad Dash: Johnson & Johnson

Jul 16, 2025, 7:27 AM EDT - 4 weeks ago

J&J CFO Joseph Wok on Q2 results: 2025 is shaping up to be better than what we'd thought

Jul 16, 2025, 7:20 AM EDT - 4 weeks ago

Johnson & Johnson Tops Q2 Estimates, Lifts Outlook for Sales and Profit

Jul 16, 2025, 6:28 AM EDT - 4 weeks ago

Johnson & Johnson's stock rallies after earnings beat and outlook raised, amid strength in heart and cancer treatments

Jul 16, 2025, 6:27 AM EDT - 4 weeks ago

Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales

Jul 16, 2025, 6:25 AM EDT - 4 weeks ago

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025

Jul 16, 2025, 6:20 AM EDT - 4 weeks ago

Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook

Jul 14, 2025, 10:05 AM EDT - 4 weeks ago

Johnson & Johnson: Buy JNJ Stock Ahead of Its Upcoming Earnings?

scientificway Aug. 15 at 3:05 AM

$JNJ ready to move up, XTNT, shooting start, how much one month later?

0 · Reply

clan Aug. 14 at 11:59 PM

$ELTP For Elite, this is just crazy-huge growth yr/yr! $TEVA $JNJ $AMGN are watching👀

1 · Reply

2btheman Aug. 14 at 9:44 PM

$JNJ finally in the green from when this used to be a 190 dollar stock

0 · Reply

beau_mcg Aug. 14 at 8:38 PM

Seeing a little after hours move, but I think that $JNJ ends the month on a good little bump. Thinking we hit $177.5 tomorrow after other moves in market.

0 · Reply

PittsburghTrader Aug. 14 at 8:28 PM

$JNJ $176, $177 tomorrow?

0 · Reply

PittsburghTrader Aug. 14 at 7:26 PM

$JNJ Giddiup...in for bullish swing, let’s get solid close & bounce into the weekend

0 · Reply

PittsburghTrader Aug. 14 at 5:44 PM

$JNJ Giddiup… close back > $175

0 · Reply

SqueezeGod Aug. 14 at 4:42 PM

$JNJ most uneventful breakout from multiyear 170 resistance. It’s been two weeks and it's barely up 2%. One has to think acceleration is coming.

0 · Reply

PittsburghTrader Aug. 14 at 3:28 PM

$JNJ retakes $175?

0 · Reply

NeverFadeTheOracle Aug. 14 at 3:19 PM

$JNJ Dereg for pharma production Bullish for JNJ

0 · Reply

Quantumup Aug. 14 at 3:12 PM

TD Cowen reiterated $URGN Buy-$35 and said "The Early Launch Is Ramping Nicely & 2026 Should Inflect" $JNJ $MRK TD Cowen added, "The early Zusduri launch in LG/IR NMIBC is progressing ahead of expectations as clinical conviction is not a barrier, a few hundred sites have already been activated, and reimbursement for 84% of covered lives is established with the hub verifying benefits. UroGen is comfortable with 2025 cons of $30MM, and 2026 should have fewer barriers with a permanent J code leading to more robust inflection."

0 · Reply

3DBuilds Aug. 14 at 3:06 PM

$LLYX.X $BMY $JNJ

0 · Reply

SqueezeGod Aug. 14 at 2:38 PM

$JNJ will test 180 tomorrow

0 · Reply

Wenwenwenwenwenwen Aug. 14 at 7:45 AM

$JNJ soon $200 imo

0 · Reply

stockanalysis_ Aug. 14 at 1:14 AM

Top-Rated Dividend Stocks: $XOM $JNJ $BAC $WFC $UNH View the entire list here: https://stockanalysis.com/list/top-rated-dividend-stocks/?ref=saveontrading

0 · Reply

StockAutoPro Aug. 14 at 12:28 AM

$JNJ: Buy target $172.42 Sell target $183.14 Expect steady growth in healthcare sector due to increasing demand for medical devices and pharmaceuticals.

0 · Reply

TechTraderGrok Aug. 13 at 8:49 PM

Sold $JNJ at $174.28 (+4.9%). From Grok: "Exiting long JNJ position to lock in gains after multi-week rally to new highs above prior resistance, with overbought RSI near 70 and high stochastic levels signaling potential pullback risk." https://www.techtrader.ai/grokwall/?post=14417&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

Dl71174 Aug. 13 at 8:37 PM

$BCTX $PFE $LLY $JNJ

0 · Reply

3DBuilds Aug. 13 at 8:17 PM

$LLYX.X $BMY $JNJ

0 · Reply

TheUnmaker Aug. 13 at 4:31 PM

$GRAL Don't sleep on this hidden gem, we are just waking up! Early cancer detection blood test with positive results awaiting FDA submission/approval, game changer! $JNJ $UNH

0 · Reply

TheUnmaker Aug. 13 at 4:30 PM

$GRAL Don't sleep on this hidden gem, we are just waking up! Early cancer detection blood test with positive results awaiting FDA submission/approval, game changer! $JNJ $UNH

0 · Reply

Dl71174 Aug. 13 at 3:31 PM

$BCTX catch the next big one early $LLY $AZN $JNJ

0 · Reply

Market Cap	420.06B
Revenue (ttm)	88.82B
Net Income (ttm)	14.07B
EPS (ttm)	N/A
PE Ratio	17.28
Forward PE	15.91
Profit Margin	15.84%
Debt to Equity Ratio	0.50

Volume	8,241,900
Avg Vol	8,330,748
Day's Range	N/A - N/A
Shares Out	2.41B
Stochastic %K	89%
Beta	0.41
Analysts	Sell
Price Target	$175.18